Six patients had frequent episodes of atrioventricular junctional rhythm during long-term oral verapamil therapy. In no instance was this rhythm associated with symptoms or adverse effects, nor did it force a discontinuation of therapy or a reduction in verapamil dosage. In the patient receiving oral verapamil therapy, atrioventricular junctional rhythm should not be considered a manifestation of drug toxicity.
|Original language||English (US)|
|Number of pages||2|
|Journal||JAMA - Journal of the American Medical Association|
|State||Published - Jan 21 1983|
ASJC Scopus subject areas